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EXECUTIVE SUMMARY

It is estimated that 222 million women in the developing world have an unmet need for contraception. The
high level of unmet need is partly due to the limited
use of contraception by women during the first six to
12 months postpartum and high discontinuation rates
with about half of all users abandoning their methods
six months after adoption. New methods that offer
greater ease of use, are women-controlled, and do
not require significant health infrastructure or medical
provider involvement for service delivery have the potential to increase family planning uptake during the
postpartum period and reduce discontinuation rates.
One such method is the progesterone vaginal ring
(PVR), a user-controlled, mid-acting contraceptive that,
according to clinical trial data, is safe and effective for
breastfeeding women.
The Population Council has embarked on a threeyear project to explore the acceptability of the PVR
among women in sub-Saharan Africa and to develop
a strategic plan for its introduction. Between February and May 2012, assessments were undertaken in
Kenya to map the landscape of family planning programs and new contraceptive technologies, identify
national priorities, and assess the level of interest in
the PVR among stakeholders in order to inform the
design of appropriate pre-introductory activities. The
assessments involved: (1) review of Demographic
and Health Surveys (DHS) data; (2) desk review of

documents, project reports and policy guidelines;
and (3) key informant interviews with representatives of government, regulatory, and development
agencies; social marketing organizations; research
institutions; manufacturers/distributors; the community; advocacy groups; public/private partnerships;
and other organizations providing family planning
services.
This report presents the findings of the assessments with specific focus on: (1) the country’s
demographic profile; (2) the health systems, health
policy, and family planning program context; and (3)
stakeholder perspectives regarding the PVR. The findings suggest that the introduction of the PVR would fill
a gap in the family planning needs of breastfeeding
women in Kenya. In addition, there is strong support
from stakeholders for future introduction of the PVR.
Given the health system challenges (staffing and
infrastructure), there is a need for contraceptives that
require little training on the part of the provider, do
not require a sophisticated health infrastructure, are
long-acting and thus do not require monthly visits to a
health center, are user-friendly and woman-controlled,
and are safe. The PVR addresses all of these concerns and based on the information documented thus
far, is likely to be a welcome addition to the existing
contraceptive method mix in the country.

v

Introduction
While the progress made in recent decades in fertility
reduction has been impressive, still up to 222 million
women in the developing world report an unmet need
for contraception (Singh and Darroch 2012). Part of the
challenge in addressing current levels of unmet need is
the limited use of contraception by women during the
first six to 12 months postpartum and the discontinuation rates with about half of all users abandoning their
methods six months after adoption. Both issues lead to
limited success in effective birth spacing, which then
can negatively impact maternal and infant health. New
methods are needed that offer greater ease of use, are
women-controlled and do not require significant health
infrastructure or medical provider involvement for
service delivery. One such method is the progesterone
vaginal ring (PVR), a user-controlled, mid-acting contraceptive that, according to clinical trial data, is safe and
effective for breastfeeding women.
The Population Council has embarked on a threeyear project to explore the acceptability of the PVR
among women in sub-Saharan Africa and to develop
a strategic plan for its introduction. From February to
May 2012 assessments were undertaken in potential study countries—Kenya, Nigeria, and Senegal—to
map the landscape of family planning programs and

new contraceptive technologies in an effort to identify
national priorities and assess the level of interest in the
PVR among stakeholders and to design appropriate preintroductory activities. The Council’s research teams
in each of these countries employed three approaches
to develop country-specific reports: review of Demographic and Health Survey (DHS) data, desk review of
documents, project reports and policy guidelines, and
key informant interviews. Interviews were held with
representatives of key government, regulatory, and
development agencies; social marketing organizations;
research institutions; manufacturers/distributors, the
community; advocacy groups; public/private partnerships; and other organizations providing family planning
services. This report presents the findings from the
stakeholder mapping exercise in Kenya. It begins by
describing the country’s demographics and unmet need
for contraception. It then provides the reproductive
health and family planning context as well as the contraceptive program and policy context before concluding with the stakeholder support known thus far and a
discussion of what this could mean moving forward with
regard to PVR introduction.

DEMOGRAPHIC PROFILE
The population of Kenya more than doubled over a
period of three decades from 10.9 million people in
1969 to 28.7 million by 1999 (CBS 1970; CBS 2001).
In 2009, it was 38.6 million and is projected to reach
64 million by 2030 (KNBS 2010). In addition, nearly
two-thirds (63%) of the population is under the age of
25 years (64% of the men and 63% of the women),
while 43% is aged below 15 years (44% of the men and
42% of the women) (CBS 2001).
The steady increase in the country’s population and
the huge proportion of young people are partly due to
previous high fertility rates and initial rapid declines in
under-five mortality. Kenya had one of the highest fertility rates (8.1 children per woman) in the world as of
1978 (CBS 1981). The fertility rate declined by almost
half over a period of two decades to 4.7 children per
woman by 1998, one of the most rapid declines ever
documented (NCPD and CBS 1999). However, between
1998 and 2008–2009, the fertility rate remained
largely unchanged at 4.7 and 4.6 children per woman
by 1998 and 2008-2009 respectively (CBS, MOH, and
ORC Macro 2004; KNBS and ICF Macro 2010).
1

DEMOGRAPHIC SNAPSHOT
Population: 38.6 million
Projected
	population in 2030: 64 million
Growth rate: 2.8%
Total fertility rate: 4.6 children per woman
Maternal
	mortality ratio: 488/100,000
Infant
	mortality rate: 74/1,000
Births occurring
	withIN 24 months
	after prior birth: 23%
HIV INCIDENCE: 6.3%

The country also experienced rapid declines in
under-five mortality between the early 1960s and early
1980s from 211 deaths per 1,000 live births by 1962
to 105 deaths per 1,000 live births by 1989, but this
progress slowed in the early 1990s (Ikamari 2004).
Although the under-five mortality rate had declined to
74 deaths per 1,000 live births by 2008–2009, the
levels remain unacceptably high. Maternal mortality, on
the other hand, declined from 590 maternal deaths per
100,000 live births in 1998 to 414 by 2003 before increasing to 488 by 2008-2009. HIV prevalence among
adults aged 15–49 years remained fairly unchanged
over a period of five years at 6.7% in 2003 and 6.3% in
2008–2009 [CBS, MOH, and ORC Macro 2004; KNBS
and ICF Macro 2010).
The Kenya government recognizes that sexual and
reproductive health care, including family planning
information and services, is a key intervention area

for improving the health of women, men, and children.
The country’s demographic patterns (rapid population
growth, high fertility rates, and high levels of maternal
and under-five mortality) are therefore likely to put a
heavy demand on reproductive health services, including family planning.
Kenya’s contraceptive prevalence rate (CPR)—the
percentage of currently married women of reproductive age (15–49 years) using any method of family
planning—increased more than five times from 7% in
1978 to 39% in 1998, which corresponds to the period
when fertility rates declined by almost half (KNBS 2010;
CBS 1981). The CPR stalled at 39% between 1998 and
2003 before increasing to 46% by 2008-2009 CBS
1981; NCPB, CBS and MI 1999; CBS, MOH, and ORC
Macro 2004). Over the same period, the proportion of
currently married women who would like to delay or limit
childbearing increased from 72% to 76% (Table 1). The
level of unmet need for family planning—the percentage
of currently married women who either do not want any
more children or want to wait two or more years before
having another child but are not using contraception—
was about 25% (from 24% in 1998 to 26% in 2008–
2009; see Table 1). The indicators in Table 1 show that
over the years, women on average desire fewer children
than they actually give birth to.
While competing health program and funding priorities may have contributed to the lack of significant
progress in fertility and family planning indicators noted
in Table 1 (Askew et al. 2009), the Kenya government
embarked on deliberate and conscious efforts to reposition family planning in the national development agenda
described in the next section.

table 1: Kenya fertility and family planning indicators
Total	
Total	
Would like to	
Unmet need
	fertility	wanted	delay or limit	for
Survey year	rate	fertility rate	childbearing	contraception

1998

4.7

3.5

72%

24%

2003

4.9

3.6

73%

25%

2008–09

4.6

3.4

76%

26%

SOURCE: Kenya Demographic and Health surveys 1998, 2003, 2008–09
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HEALTH SYSTEMS
OVerVIEw
Health Systems
The major healthcare providers in Kenya, the Ministry
of Public Health and Sanitation and the Ministry of
Medical Services, operate over half of all health facilities around the country. These public health facilities
remain the major source of family planning and reproductive health services. Fifty-seven percent of women
obtain a form of modern contraception from a public
health facility, with the rest obtaining methods from
private health facilities (36%) and other sources such
as mobile clinics, community-based distributors, local
shops, and friends and family (6%).

The second National Health Sector Strategic Plan
(NHSSP II) of 2005–2010 outlined six levels of health
service delivery in the country under the Kenya Essential Package for Health (KEPH) (Republic of Kenya
MOH 2005). These include the community (Level 1);
dispensaries and clinics (Level 2); health centers,
maternity and nursing homes (Level 3); primary,
subdistrict, district, and mission hospitals (Level 4);
secondary and provincial hospitals (Level 5); and
tertiary hospitals (Level 6). Table 2 summarizes the
family planning services delivered at each level as
well as the available service providers.
Family planning services are also provided through
private pharmacies and social marketing programs.
According to the National Family Planning Guidelines
for Service Providers, private pharmacies should coun-

Table 2: Levels of family planning service delivery in Kenya
LEVEL

SERVICE PROVIDERS

FAMILY PLANNING SERVICES

LEVEL 1:
Community

• Community health workers (CHWs)
• Community health extension workers
(CHEWs)
• Community midwives

• Family planning counseling
• Provision of condoms
• Referral for other methods

LEVEL 2:
Dispensaries
and clinics

• Nurse/midwife
• Public health technician
• CHEWs

• Family planning counseling
• Provision of condoms, pills, injectables
• Provision of implants and IUCD
depending on training
• Referral for other methods

LEVEL 3:
Health centers,
maternity and
nursing homes

• Doctor (outreach)
• Clinical officer
• Nurse/midwife
• Public health technician
• CHEWs

• Family planning counseling
• Provision of condoms, pills, injectables
• Provision of implants and IUCD
depending on training
• Provision of bilateral tubal ligation and
vasectomy as outreach
• Referral for other methods

LEVEL 4:
Primary,
subdistrict,
district, and
mission hospitals

• Doctors
• Clinical officer
• Nurse/midwife
• Public health officer or technician

• Family planning counseling
• Provision of full range of family
planning methods

LEVELS 5 and 6:
Secondary,
provincial, and
tertiary hospitals

• Doctors (including specialists)
• Clinical officer
• Nurse/midwife

• Family planning counseling
• Provision of full range of family
planning methods

Source: Division of Reproductive Health (DRH)/Ministry of Public Health and Sanitation (MOPHS). 2010. National Family Planning Guidelines for Service Providers. Nairobi: DRH/MOPHS; pp.38–40.; IUCD: Intrauterine contraceptive device
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sel clients on and provide or sell condoms, pills, injectables, implants, and Standard Days Methods (SDM)
(DRH and MOPHS 2010). In addition, they should refer
clients for lactational amenorrhea methods (LAM),
injection, intrauterine contraceptive device (IUCD),
other fertility-based awareness methods (FAM), and
sterilization. Social marketing programs are, on the
other hand, expected to promote, sell, or refer clients
for most of the family planning methods except FAM
and sterilization where the guidelines stipulate that
they should only refer clients (DRH and MOPHS 2010)

FAMILY PLANNING AND
REPRODUCTIVE HEALTH
POLICY CONTEXT
Kenya was the first sub-Saharan African country to
establish a national family planning programme
(which was regarded as an African success story)
through the National Family Planning Policy (NFPP)
of 1967. However, it was not until 1984 that the first
population policy—Population Policy Guidelines—was
developed. A number of population and health policies have since been put in place especially since the
1994 International Conference on Population and
Development (ICPD).
The National Population Policy for Sustainable
Development was developed in 2000. The Policy
widened the scope for addressing population issues
by integrating a domestic Programme of Action of
the ICPD. It had the objectives of: (1) improving the
standards of living and the quality of life of the people;
(2) fully integrating population concerns into the
development process; (3) motivating and encouraging Kenyans to adhere to responsible parenthood; (4)
promoting the stability of the family; (5) empowering
women and eliminating retrogressive socio-cultural
practices such as female genital mutilation; and (6)
integrating the youth, the elderly, and persons with
disabilities into the mainstream in national development (NCPD 2000).
In 2003, the government developed the Adolescent
Reproductive Health and Development Policy with
one of its key targets being to double the contraceptive prevalence rate among adolescents aged 15–19
and youth aged 20–24 years by 2015 (NCPD and
DRH). Since 2005, the government has embarked on
4

deliberate and conscious efforts to reposition family
planning in the national development agenda. Key
among these efforts was the development of the first
National Reproductive Health Policy in 2007 that outlined family planning as one of the priority reproductive health components and recognized that the available family planning methods do not allow for a wide
method choice (MOH 2007). The policy’s aim was to
guide planning, standardization, implementation, and
monitoring and evaluation of reproductive health care
provided by various stakeholders. The policy allowed
the government to incorporate and address key issues
such as security of reproductive health commodities,
prevention of mother-to-child transmission of HIV,
emergency obstetric care, adolescent reproductive
health issues, gender-based violence, reproductive
health needs of persons with disabilities, and integration of reproductive and HIV health care (MOH 2007).
In 2008, the government developed a strategy
to increase the uptake of long-acting or permanent
methods (LAPMs). One of the areas of focus for the
strategy was ensuring a wider availability of method
choices through enhanced commodity security, equipment and supplies (MOPHS/DHR 2008). In 2009,
the government unveiled a strategy for the period
2009–2015 to guide the implementation of the
National Reproductive Health Policy. The objectives
of the strategy with respect to family planning are to
reduce unmet need, unplanned births, and regional
and socioeconomic disparities in the CPR (MOPHS
and MOMS 2009).
In 2010, the government issued revised National
Family Planning Guidelines for Service Providers that
outlined the recommended practices in the provision of family planning services in the country (DRH/
MOPHS 2010). The guidelines further addressed
issues relevant for the provision of family planning
services including enhancing the functions of community health workers and community-based distributors and male involvement. The government also
convened the National Population Leaders’ Conference in Nairobi. The conference provided leaders
from around the country with an opportunity to: (1)
address critical population issues—including repositioning family planning – that affect the quality of
life of Kenyans; and (2) shape clear, succinct, and
understandable messages about these issues for the
general population.

The government further formulated other development policies that have direct bearing on population and health issues. For instance, following the
adoption of the United Nations (UN) Millennium
Development Goals (MDGs) in 2000, the government
launched MDG-based planning and budgeting
in 2004. The MDGs include targets to be achieved
by 2015 in the areas of eradicating poverty and hunger, achieving universal primary education, promoting
gender equality, reducing child mortality, improving
maternal health, combating HIV/AIDS and other
diseases, reducing environmental degradation, and
fostering partnerships with international development
partners (Republic of Kenya 2005).
Kenya has taken many steps to ensure that reproductive health and family planning are at the center
of the national agenda by recognizing the need for
expanding contraceptive choice, setting time-based
objectives to see improvements in related indicators,
and repositioning family planning. The policy environment in Kenya is therefore open to and supportive of
new-method introduction.

FAMILY PLANNING AND
REPRODUCTIVE HEALTH
PROGRAM CONTEXT
Healthcare Utilization Patterns
Estimates from the 2008–2009 Kenya Demographic
and Health Survey (KDHS) show that whereas 92%
of expectant women in the country receive antenatal
care from skilled providers, only 43% of births occur
in health facilities while another 44% of births are
delivered under skilled care (KNBS and ICF Macro
2010). In addition, only 47% of the mothers report
receiving a postnatal check-up after the birth (KNBS
and ICF Macro 2010). However, more than threequarters (77%) of the children aged between 12 and
23 months are fully immunized (KNBS and ICF
Macro 2010).
There are wide regional and socioeconomic variations in the use of reproductive health services in
the country. For instance, the proportion of women
delivering in a health facility is more than twice as
high in the urban compared to rural areas (75% and

35%, respectively) and more than four times higher
among women from the richest compared to those
from the poorest households (81% compared to 18%,
respectively). It is also more than three times higher
in Nairobi compared to North Eastern province (89%
and 17%, respectively). A similar pattern is noted with
respect to contraceptive use. In particular, the contraceptive prevalence rate (CPR) in urban areas is 53%
while it is lower in the rural areas (43%). CPR is also
more than twice as high among women from the richest households compared to those from the poorest
households (55% and 20%, respectively) and more
than 16 times higher in Central compared to North
Eastern province (67% and 4%, respectively).

Contraceptive Use and Method Mix
The family planning methods available in Kenya are:
(1) hormonal methods: including combined oral contraceptives (COCs); Progestin-only contraceptive pills,
Progestin-only injectable contraceptives (DMPA, NETEN); Progestin-only contraceptive implants (Jadelle,
Implanon, Zarin, Sino-Implant); and dedicated
emergency hormonal contraceptive pills (Postinor2,
Pregnon, Smart Lady, ECee2, Truston2); (2) IUCDs:
copper-based devices (Copper T380A) and hormonereleasing Intra-Uterine Systems (Mirena LNG-20IUS);
(3) voluntary surgical contraception for women (tubal
ligation or female sterilization) and men (vasectomy
or male sterilization); (4) barrier methods: male and
female condoms, diaphragms, cervical caps, and
spermicides; although the use of diaphragms, cervical
caps and spermicides is negligible; (5) lactational
amenorrhoea method (LAM): lack of ovulation which
results from exclusive breastfeeding; and (6) FAMs:
calendar-based methods such as the Standard Days
Method® (SDM); symptoms-based methods such
as the. TwoDay Method® (TDM), Cervical Mucus
or Billings Ovulation Method, Basal Body Temperature (BBT), and Sympto-thermal Method (Cervical
Mucus+BBT); and withdrawal or coitus interruptus
method (DRH/MOPHS 2010).
Modern family planning methods are the most
commonly used contraceptives (by 39% of currently
married women) compared to traditional methods
such as rhythm, withdrawal, or folk methods. Over
the years, injectables have been the most commonly
used modern of family planning methods followed by
the pill and female sterilization (Figure 2). The use of
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FIGURE 2: TRENDS IN USE OF SPECIFIC
FAMILY PLANNING METHODS

injectables almost doubled from 12% in 1998 to 22% in
2008–09 while the use of pills declined from 9%
to 7% over the same period (Figure 2). The use of female sterilization, on the other hand, declined from 6%
in 1998 to 4% in 2003 before slightly increasing to 5%
in 2008–09. Preference for injectables is also evident
among married women who are not using contraceptives but intend to use in future: slightly more than half
(52%) prefer injectables, 12% prefer the pill, 8% prefer
female sterilization, and another 8% prefer implants.
Sino-Implant was the last contraceptive method to
be introduced in Kenya. Experience from its introduction
shows that the country of origin/manufacturer is critical
in influencing people’s perceptions about the product.
In addition, experiences from the introduction of other
methods such as emergency contraceptives show that
products that are user-controlled are quite popular with
clients as opposed to those that are solely provided by
healthcare workers. The involvement of government officials from the outset of product introduction planning
is also critical as is the need for repeat training and
technical supervision of service providers during the
introduction process (Keesbury et al. 2009; Shauri and
Vail 2009). It is also worth noting that the use of and
attitudes surrounding hormonal contraception in Kenya
appear to be unchanged in light of the recent inconclusive evidence regarding hormonal contraception and
the acquisition of HIV (MOPHS 2011).

6

Since the PVR is a product that is self-inserted into
the vagina, the use of other vaginal products may serve
as a proxy for its uptake. Products that are inserted into
the vagina, such as the diaphragm and menstrual cups,
have received mixed reactions in Kenya. For instance,
in a study conducted in Mombasa among female sex
workers, the diaphragm was found to be an acceptable method with high user satisfaction (Luchters et
al. 2007). In contrast, in a study of the acceptability of
the menstrual cup in Nairobi, most participants encountered discomfort while some complained that they
could feel the cup in their vaginas or some pain at the
first attempt (APHRC 2010). There is no literature on
the use of tampons in Kenya. However, a study in the
United States found that tampon users were more likely
to choose the contraceptive vaginal ring than combined
oral contraceptive pills.

Postpartum Family Planning
The level of family planning in the postpartum period
remains low in the country with only 25% of postpartum
women using a family planning method compared to
the national CPR of 46% (KNBS and ICF Macro 2010;
Gebreselassie, Rutstein, and Mishra 2008). In addition, the level of unmet need for family planning is
more than twice as high among postpartum women
(68%) compared to those in the general population
(26%) (KNBS and ICF Macro 2010; Gebreselassie,
Rutstein, and Mishra 2008). The postpartum period is
also characterized by a limited range of available family
planning methods that include LAM, IUCD, sterilization,
progestin-only pills, injectables, and condoms, with
injectables being the dominant contraceptive method
used (Gebreselassie, Rutstein, and Mishra 2008).. The
Ministry of Health therefore recognizes the need for
family planning information and services during the
postpartum period as an integral component of maternal and neonatal care services (DRH/MOPHS 2010).
However, programs to strengthen family planning
service provision during the postpartum period have
to date been donor-driven and implemented on a pilot
basis in selected districts (Mwangi et al. 2008; Chebet
and Jahonga 2011). These programs have, however,
demonstrated substantial improvements in the uptake
of family planning in the postpartum period (Mwangi et
al. 2008; Chebet and Jahonga 2011).

breastfeeding policies
and practices
With respect to breastfeeding practices, nearly all children under five years of age (97%) are ever breastfed.
In addition, mothers initiate breastfeeding within one
hour of birth for 58% and within one day of birth for
86% of the children ever breastfed. Forty-two percent
of the children are given something other than breast
milk (pre-lacteal liquids) during the first three days of
life. The most commonly given pre-lacteal liquids include plain water (37%), sugar or glucose water (27%),
sugar and salt water (23%), and other milk (13%).
Other pre-lacteal liquids include gripe water (5%), fruit
juice (1%), infant formula (2%), and tea/infusions
(3%). The median duration for any breastfeeding is 21
months while the median duration for exclusive breastfeeding is less than one month. The median duration
of breastfeeding is longer in rural than in urban areas
(21 and 19 months, respectively) and in North Eastern
compared to Nairobi province (26 and 15 months, respectively). Ninety-three percent of children under the
age of six months are breastfed six times or more in a
24-hour period.
Only 32% of children under six months of age are exclusively breastfed. This proportion is highest (52%) for
children aged 0–1 month; after 8 months, the proportion of children being exclusively breastfed declines to
less than 1%. Therefore, there is a strong case for the
progesterone vaginal ring since exclusive breastfeeding
is not highly practiced and the hormones in the PVR
are natural and therefore will not affect breastfeeding.
However, in September 2012, parliament passed a
law aimed at promoting exclusive breastfeeding for the
first six months and continuous breastfeeding after the
introduction of other foods up to a period of 24 months.
The law has, however, been criticized for seeking to
regulate the marketing, promotion, distribution, and
sale of breast milk substitutes rather than promote

exclusive breastfeeding (Maina 2012). The government
has also formulated several policies aimed at protecting, promoting and supporting optimal infant feeding
practices (Republic of Kenya/MOPHS 2012).

Securing Contraceptive
Commodities and Getting Them to Market
For many years, the commodities and drug procurement system in Kenya was based on the “push system,” or one that anticipates future needs and furnishes products in advance of those needs. However, in
the past two years, Kenya has been experimenting with
the “pull system,” or one that supplies orders that have
already been filled. By November 2011, four provinces
were piloting the “pull system” while the other four
continued to use the “push system.”
The current strategic plan (2011–2015) for the
Division of Reproductive Health addresses three main
priority areas: demand creation, family planning commodity security, and adolescent health. There exists a
strategic plan on reproductive health and family planning commodities that emphasizes:
• Regular updating of the commodity procurement
plan reflecting Kenya government and donor commitment;
• Timely procurement to ensure a full product pipeline;
• Improvement in technical capacity for forecasting
and quantification at the district level; and
• Improvement in district oversight of the supply chain
and the commodity information system.
The Pharmacy and Poisons Board of Kenya is responsible for the overall regulation of new drugs and
medical devices in Kenya. The board has published a
number of guidelines to regulate clinical trials in Kenya

Breastfeeding in Kenya
Children ever breastfed: 97%
Median duration for any breastfeeding: 21 months
Median duration for exclusive breastfeeding: < 1
	
  

month
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Table 3: Stakeholders consulted during country mapping
Stakeholder type

Name of Institution

Government agencies & policymakers

Ministry of Public Health and Sanitation-Division of Reproductive Health

Regulatory & quality assurance agencies

Pharmacy & Poisons Board

Private-sector providers (family planning/
postpartum care)

Organization for Health, Education and Research Services
(OHERS)- Non-governmental organization

Public/private partnership for health provider (including family planning/postpartum care)

Kenya Urban Reproductive Health Initiative (KURHI-Jipange,
Jhpiego)

Other organizations providing family planning/postpartum care

Marie Stopes, IPPF

Development agencies

USAID, WHO, UNFPA, KfW

Social marketing

Population Services International (PSI)

Community representative & advocacy groups

Maendeleo ya Wanawake Organization (MYWO)

Professional associations

Kenya Obstetrical and Gynaecologcal Society (KOGS) (FIGOAffiliate)

Research institutions

FHI 360

Drug manufacturers/distributors

Bayer East-Africa

Notes: IPPF: International Planned Parenthood Federation; USAID: United States Agency for International Development; WHO: World Health
Organization; UNFPA: United Nations Population Fund; KfW: Kreditanstalt für Wiederaufbau (German Development Bank); FIGO: International
Federation of Gynecology and Obstetrics.

as well as on the submission of documentation for
registration of medical devices and drugs. The Board is
also responsible for approving the importation of limited
quantities of drugs, including the PVR, into Kenya for
the purpose of carrying out research activities.

Service Delivery
Stakeholders in Kenya were consulted to identify where
and how they thought the PVR would be most successfully integrated into the health system. All stakeholders agreed that there should be no parallel systems
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and that the PVR should be distributed through either
the private or public sector. Most participants favored
introduction of the PVR through the public sector (6
out of 10). A few stakeholders voiced preference for
introduction through the private sector (3 out of 10),
and one stakeholder suggested that the nongovernmental organization (NGO) sector would be a good channel.
Kenya’s policy environment with regard to reproductive
health and family planning is supportive of the introduction of new contraceptives regardless of the channel of
distribution.

Support for the PVR

DISCUSSION

The consensus arising from the stakeholder consultations was that the PVR is seen as an important addition
to the family planning method mix for postpartum women. Stakeholders would like to learn more about pricing
and potential positioning of the product. They also had
concerns about whether the product has been registered by the US Food and Drug Administration (which it
has not due to the fact that breastfeeding is not as universal or prolonged). Other logistical and practical considerations were also discussed to determine areas that
should be addressed for successful introduction of the
product. Most emphasized learning from the experience
of Sino-Implant, particularly with respect to the country
where the product is manufactured, which is critical in
influencing people’s perception. In addition, recommendations were made to plan for advocacy activities and
enlist female gynecologists as advocates to talk about
the product in various forums and with women’s group
leaders. Stakeholders also advocated getting the PVR
on the World Health Organization’s Essential Commodities List. The potential support for the PVR among users,
partners, providers, and community members will be
determined through acceptability studies.

After consideration of how family planning is perceived
in Kenya’s socio-cultural and political environment and
an analysis of the health system infrastructure, it appears that the introduction of the PVR would fill a gap
in the family planning needs of breastfeeding women in
Kenya. The strong support for future introduction of the
PVR and the more immediate acceptability studies the
Council is conducting as part of pre-introductory efforts
further underscore the potential for the PVR to fill this
gap. There is a need for contraceptives that require little
training on the part of the provider, do not require a
sophisticated health infrastructure; are long-acting and
thus do not require monthly visits to a health center,
and are user-friendly, woman-controlled, and safe. The
PVR addresses all of these concerns and based on the
information documented thus far, is likely to be a welcome addition to the existing contraceptive method mix.

Stakeholder recommendations for
introduction
1. Find an advocate
2. Develop a dossier of safety and efficacy
evidence to help fast-track registration
3. Avoid simultaneous introduction into multiple sectors (public and private)
4. Address any myths and misconceptions
5. State benefits to woman, child and partner
6. Focus on the PVR’s ease of use
7. Emphasize pharmacist training if product
is to be available over the counter
8. Address question of product pricing
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LIST OF STAKEHOLDERS INTERVIEWED

Date

Organization

Person(s) seen

02.05.2012

Marie Stopes International

Dr. Edwin Mbugua
Louise Patterson
Dr. Mark Ayallo
Gabrille Appleford
Dr. Cleophas Ondieki

04.05.2012

USAID

Sheila Macharia
Emily Iruguthu

Division of Reproductive Health (DRH)

Dr. Shiphrah Kuria
Dr. Agnes Nakato
Dr. Pamela Godia
Dr. Gathari Ndirangu
John Mwang
Damaris Mwanzia
Anne Njeru

11.05.2012

FHI 360

Dr. Marsden Solomon

14.05.2012

Bayer East Africa

Dr. Bernard Matheka
Mr. Bernard Mutua
Mr. Kuto

14.05.2012

Kfw

Julia Fimpel

15.05.2012

KURHI-JIPANGE/Jhpiego

Mr. Nelson Keyonzo
Dr. Janet Omyonga

15.05.2012

PSI

Anthony Okoth
Joyce Maina-Wanderi
Susan Karimi

16.05.2012

World Health Organization (WHO)

Dr. Joyce Lavussa

21.05.2012

Kenya Obstetrics and Gynecological Society (KOGS)

Dr. Guyo Jaldesa

21.05.2012

Organization for Health, Education and Research Services
(OHERS)

Mrs. Nelly Luchemo
Maureen

21.05.2012

Maendeleo Ya Wanawake Organization (MYWO)

Susan Atieno Chege

22.05.2012

The International Planned Parenthood Federation

Dr. Lawrence Oteba

25.05.2012

UNFPA

Dr. Stephen Wanyee
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